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Randall C. Starling, MD, MPH, FACC, Bruce L. Wilkoff, MD, FACC,
W. H. Wilson Tang, MD, FACC
Cleveland, Ohio
Objectives Our aim was to determine the potential hemodynamic contributions of cardiac resynchronization therapy (CRT)
in patients admitted for advanced decompensated heart failure.
Background CRT restores synchrony of the heart resulting in hemodynamic support that can facilitate the reversal of left ven-
tricular (LV) remodeling in some patients.
Methods A total of 40 consecutive patients with advanced decompensated heart failure and CRT implanted 3 months,
admitted due to hemodynamic derangements, underwent simultaneous comprehensive echocardiographic and
invasive hemodynamic evaluation under different CRT settings.
Results All patients (mean LV ejection fraction 22  7%, LV end-diastolic volume 323  140 ml, 40% ischemic) had
experienced progressive cardiac remodeling despite adequate LV lead positions and continuous biventricular
pacing. A significant worsening of hemodynamics was observed immediately when CRT was programmed OFF in
the majority (88%) of patients (systolic blood pressure: 105  12 mm Hg to 98  13 mm Hg; pulmonary capil-
lary wedge pressure: 17  6 mm Hg to 21  7 mm Hg; cardiac output: 4.6  1.4 l/min·m2 to 4.0  1.1
l/min·m2; all p  0.001). Worsening of hemodynamics coincided with reappearance of significant electrical
(QRS width 161  29 ms to 202  39 ms, p  0.001) and intraventricular mechanical dyssynchrony (15  26
ms to 57  41 ms, p  0.001), together with a significant reduction in diastolic filling time (377  138 ms to
300  118 ms, p  0.001).
Conclusions Despite progressive cardiac remodeling and decompensation, chronic CRT continues to provide hemodynamic
augmentation in the failing heart in most patients. Our data suggest that disease progression may not be
explained by diminished beneficial hemodynamic contributions of successful resynchronization. (J Am Coll
Cardiol 2009;53:600–7) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.08.079r
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hardiac resynchronization therapy (CRT) restores the co-
rdination of contraction and relaxation among cardiac
hambers, leading to a better survival in patients with
dvanced heart failure and evidence of ventricular conduc-
ion delay (1–3). The primary contribution of CRT is
hought to be the restoration of hemodynamic support from
coordinated heart that might facilitate the reversal of
athophysiologic processes. While the extent of hemody-
amic improvement is only an indicator of early response,
rom the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland,
hio. Drs. Grimm, Starling, Wilkoff, and Tang are consultants for Medtronic Inc.
rs. Wilkoff and Tang are consultants for Boston Scientific, Inc. Drs. Grimm and
ilkoff are consultants for St. Jude. The authors had full access to the data and take
esponsibility for its integrity.n
Manuscript received May 5, 2008; revised manuscript received August 29, 2008,
ccepted August 31, 2008.eversal of basal dyssynchrony by CRT has proven to be a
etter indicator of chronic response and cardiac remodeling
reduction in left ventricular [LV] volumes, and improve-
ent in LV ejection fraction) (4–9). However, as with any
ffective therapy for patients, responses are often heteroge-
eous and patients may not see any improvement in clinical
tatus and/or reversal of cardiac remodeling after 3 to 6
onths of CRT (2,10–13). Therefore, one might postulate
See page 608
hat “nonresponders” may experience a diminished hemo-
ynamic benefit by CRT over time. Although discordance
etween clinical and echocardiographic response to CRT
as been observed in prior studies, the degree of hemody-
amic response in the absence of a robust echocardiographic
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February 17, 2009:600–7 Persistent Hemodynamic Benefits of CRTemodeling to long-term CRT has not been explored (14).
erein, we aim to examine the contributions of biventricu-
ar pacing to the clinical, hemodynamic, and echocardio-
raphic profiles of patients admitted with advanced heart
ailure and evidence of disease progression despite long-
erm CRT therapy.
ethods
tudy population. We prospectively enrolled 40 consecu-
ive patients who had received a CRT plus defibrillator
evice for at least 3 months, and were subsequently admit-
ed to the Cleveland Clinic heart failure intensive care unit
etween October 1, 2007, and February 20, 2008, due to
emodynamic compromise. The CRT device was always
mplanted because of stable but advanced heart failure (New
ork Heart Association [NYHA] functional class III or IV)
espite optimal medical therapy, including angiotensin-
onverting enzyme inhibitor and/or angiotensin receptor
locker, beta-blocking agent, and spironolactone, for at least
months, a depressed LV ejection fraction (35%), and
rolonged QRS duration (120 ms). Exclusion criteria
ncluded: 1) patients on artificial ventilation; and 2) status
fter cardiac transplantation or congenital heart disease. The
leveland Clinic Institutional Review Board approved this
esearch project, which is part of the standard clinical
valuation tailored for patients admitted to our heart failure
ntensive care unit.
RT optimization protocol. Data reported were col-
ected during a CRT optimization protocol as part of
tandard evaluation within 24 h of admission to the heart
ailure intensive care unit. Briefly, an electrocardiogram
nd anterior-posterior and lateral chest X-ray were per-
ormed to ensure biventricular pacing and adequate
ositions of the right atrial, right ventricular, and LV
eads (basal or midlateral/posterior position). A compre-
ensive device interrogation was then performed includ-
ng assessment of battery status, lead impedances and
hresholds, heart rate and activity histograms, percentage
f atrial and ventricular pacing, and presence of atrial and
entricular tachyarrhythmias.
Hemodynamic and echocardiographic data were then
imultaneously collected with nominal settings of the CRT
evice (“CRT-ON”). Next, the CRT device was pro-
rammed into a nonfunctional pacing mode (VVI, backup
0 beats/min) for 10 min, after which collection of hemo-
ynamic and echocardiographic data were repeated (“CRT-
FF”). No changes in intensive medical therapy were made
uring the entire pacing protocol. If the patient had no
nderlying atrial rhythm or a total atrioventricular (AV)
odal block, the pacemaker could be programmed in an
AI or DDD mode, respectively, at similar heart rates as
he nominal settings (only 2 patients of study population, 1
n AAI and 1 in DDD). After completion, the device was
eprogrammed in a CRT mode, and the AV interval was
ptimized using conventional Doppler echocardiography t15,16). The optimal AV inter-
al was assessed by pulsed-wave
oppler at the mitral valve
eaflet tips and corresponded to
he shortest AV interval that
issociated the E- and A-wave
ut did not interrupt the end of
he A-wave (15,16). After-
ards, patients were scheduled
or long-term clinical follow-
ps and device checks. Appro-
riate actions would be taken,
uch as identifying cases of in-
dequate lead position, inap-
ropriate device programming,
rrhythmias, or improvement of
emodynamics in those with CRT-OFF.
emodynamic evaluation. Hemodynamic data, including
ystemic blood pressure, central venous pressure (CVP),
ulmonary artery pressures, and pulmonary capillary wedge
ressure (PCWP) (wedge position was verified by fluoros-
opy and phasic changes in pressure waveforms), represent
he average of 5 cycles, and with balanced transducers (0
evel at the midaxillary line). The CVP, pulmonary artery
ressures, and PCWP were assessed at end-expiration with
balloon-tipped catheter at steady state with the patient in
supine position by an investigator unaware of the echo-
ardiographic measurements. Cardiac output (CO) was
etermined using the Fick equation through averaging of 2
amples of a mixed central venous blood gas taken in the
ulmonary artery while assuming standard metabolic rates.
ystemic blood pressures were measured noninvasively by an
utomatic cuff sphygmomanometer at scheduled intervals.
ransthoracic echocardiography. A comprehensive 2-
imensional echocardiographic exam was performed with a
ommercially available system (Vingmed, System VII, General
lectric, Horton, Norway) by a cardiologist highly experienced
n echocardiography. Images were acquired in the left lateral
ecubitus position using a phased array transducer in the
tandard parasternal and apical views. Standard 2-dimensional
nd Doppler data, triggered to the QRS complex, were
igitally stored in a cine-loop format. Individuals experienced
ith echocardiographic measurements without prior knowl-
dge of clinical or hemodynamic data performed the analysis
ffline.
All reported echocardiographic measurements were aver-
ged from at least 3 consecutive cycles. LV volumes, LV
jection fraction, diastolic filling parameters (mitral E, decel-
ration time, diastolic filling time, Q-A time), transmitral, and
V outflow velocity time integral were assessed as recom-
ended by the American Society of Echocardiography (17).
nterventricular mechanical dyssynchrony was assessed as the
ifference between the pre-ejection intervals from QRS onset
o the beginning of ventricular ejection at the pulmonary and
ortic valve levels using pulsed-wave Doppler (1,2). Intraven-
Abbreviations
and Acronyms
AV  atrioventricular
CO  cardiac output
CRT  cardiac
resynchronization therapy
CVP  central venous
pressure
LV  left
ventricle/ventricular
NYHA  New York Heart
Association
PCWP  pulmonary
capillary wedge pressurericular mechanical dyssynchrony was assessed from regional
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Persistent Hemodynamic Benefits of CRT February 17, 2009:600–7ime intervals between the onset of the QRS complex and the
eak of the systolic myocardial velocity (Ts) in 4 basal segments
f the LV (septal, lateral, anteroseptal, posterior) using color
issue Doppler imaging (7).
tatistical analysis. All data were expressed as mean SD
or continuous data (median and interquartile range for
onparametric data), and as a ratio for categorical data.
nivariate comparisons of these variables were performed
etween the same patients with CRT-ON and CRT-OFF,
ubject Characteristics (n  40)
Table 1 Subject Characteristics (n  40)
Demographics
Age (yrs) 62 (53–67)
Men (%) 71
Weight (kg) 88 (70–103)
Comorbidities (%)
Hypertension 68
Hyperlipidemia 71
Diabetes 24
Heart failure etiology (%)
Idiopathic dilated 60
Ischemic 40
Medications (%)
ACE inhibitors/ARB 60
Beta-blockers 72
Spironolactone 60
Loop diuretic 92
Digoxin 36
Hydralazine 42
Isosorbide dinitrate 44
Sodium nitroprusside 50
Inotropic drugs 32
Laboratory data
Hemoglobin (g/dl) 11.6 (10.4–13.6)
Creatinine (mg/dl) 1.4 (1.0–2.2)
B-type natriuretic peptide (pg/ml) 580 (269–1,469)
alues are median (interquartile range) or %.
ACE  angiotensin-converting enzyme; ARB  angiotensin receptor blocker.
iventricular Pacemaker Diagnostics (n  40)
Table 2 Biventricular Pacemaker Diagnostics (n  40)
Sinus rhythm (%) 86
DDD configuration (%) 94
VVIR configuration (%) 6
Lower rate (beats/min) 60 10
Upper rate (beats/min) 125 15
Pacing mode
ASVS 4
ASVP 66
APVS 0
APVP 30
Paced AV interval (ms) 130 (120–160)
Sensed AV interval (ms) 120 (100–130)
VV timing (ms) 0 (0–4)
alues are %, mean  SD, or median (interquartile range).
APVP atrial pacing ventricular pacing; APVS atrial pacing ventricular sensing; ASVP atrial
ensing ventricular pacing; ASVS  atrial sensing ventricular sensing; AV  atrioventricular;
DD  atrial and ventricular pacing and sensing; VVIR  ventricular pacing and sensing only; VV
iming  interventricular timing interval.sing SPSS for Windows, release 13.0 (SPSS Inc., Chicago,
llinois). A paired t test for continuous data was used for
ppropriate comparisons. Statistical significance was set at a
-tailed probability level of 0.05.
esults
atient characteristics. Baseline characteristics and treat-
ent during admission of the 40 patients are summarized in
able 1. All patients were classified as NYHA functional
lass III (14%) or IV (86%), with a mean LV ejection
raction of 22  7% and mean LV end-diastolic volume of
Figure 1 Selected Echocardiographic Changes
in Patients With CRT-ON and CRT-OFF
CRT  cardiac resynchronization therapy; LV  left ventricle;
VMD  ventricular mechanical dyssynchrony; VTI  velocity time integral.
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February 17, 2009:600–7 Persistent Hemodynamic Benefits of CRT23 140 ml. Device and lead implantation were successful
n all patients without major complications, on average
74  410 days before enrollment into the study. Seventy-
ve percent of patients had experienced a subjective im-
rovement in 1 NYHA functional class at 3 months
ost-implant. However, at the time of study enrollment, 1.2
ospitalizations for heart failure exacerbation per patient
ad occurred. Reliable serial LV end-diastolic volumes (and
iameters) could be retrieved in 29 (72.5%) patients, and
ere found to be 266 128 ml (6.8 1.2 cm) pre-implant,
72  141 ml (6.8  1.3 cm) at 3 months post-implant
p 0.2 vs. pre-implant), and 309 133 ml (7.1 1.2 cm)
p  0.01 vs. pre-implant and 3 months) at the time of
tudy enrollment.
Device interrogation was successful in all patients
Table 2). All patients had a lead in the right atrium,
ight ventricle, and coronary sinus, including 14% of
atients that were in atrial fibrillation at enrollment. No
ead dislodgement was detected, and in 35 (87.5%)
atients, the LV lead was deemed to be in a satisfactory
ateral or posterolateral position. Patients were being
aced in a biventricular mode 96% of the time, predom-
nantly in an atrial sensing-ventricular pacing mode.
eart rates at time of study enrollment, with CRT-ON
nd CRT-OFF, were also similar (69  34 beats/min vs.
7  38 beats/min, p  NS).
mpact of biventricular pacing on echocardiographic
ariables. Acute changes in echocardiographic indexes in
ifferent settings of CRT programming are illustrated in
emodynamic and Echocardiographic Changesn Patie ts With CRT-ON nd CRT-OFF (n  40)
Table 3 Hemodynamic and Echocardiographic Changesin Patients With CRT-ON and CRT-OFF (n  40)
Variable CRT-ON CRT-OFF p Value
Heart rate (beats/min) 69 34 67 38 NS
Systolic blood pressure (mm Hg) 105 12 98 13 0.001
Central venous pressure (mm Hg) 9 7 11 7 0.001
Systolic pulmonary artery
pressure (mm Hg)
44 13 49 15 0.001
Diastolic pulmonary artery
pressure (mm Hg)
22 8 25 9 0.001
Pulmonary capillary wedge
pressure (mm Hg)
17 6 21 7 0.001
Cardiac output (l/min) 4.6 1.4 4.0 1.1 0.001
QRS width (ms) 161 29 202 39 0.001
Mitral valve regurgitation (scale 0–4/4) 1.9 0.8 2.1 1 0.001
Mitral valve E velocity (cm/s) 96 26 108 37 0.001
Mitral valve E deceleration time (ms) 178 63 159 59 0.001
LV diastolic filling time (ms) 377 138 300 118 0.001
Onset QRS until end of A-wave time (ms) 69 47 19 31 0.001
LV inflow velocity time integral 19 6 16 5 0.001
LV outflow velocity time integral 14 5 11 4 0.001
Interventricular mechanical
dyssynchrony (ms)
22 15 45 25 0.001
Intraventricular mechanical
dyssynchrony (ms)
15 26 57 41 0.001
alues are mean  SD.
CRT  cardiac resynchronization therapy; LV  left ventricle.igure 1 and Table 3. Overall, compared with CRT-ON,ative conduction (i.e., CRT-OFF) was associated with
cute worsening of LV diastolic filling, as evidenced by a
ignificant reduction in diastolic filling time, mitral valve
eceleration time, and time between QRS onset and end of
-wave. Also, acutely, the mitral valve velocity time integral
as a surrogate of the total volume of blood that entered the
V) and corresponding estimated LV stroke volume was
educed with CRT-OFF compared with that seen with
RT-ON. Furthermore, the amplitude of mitral E-wave
nd severity of mitral regurgitation increased. There was
Figure 2 Selected Hemodynamic Changes
in Patients With CRT-ON and CRT-OFF
CRT  cardiac resynchronization therapy.
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Persistent Hemodynamic Benefits of CRT February 17, 2009:600–7lso evidence of increased electrical dyssynchrony (i.e., QRS
idth) as well as inter- and intraventricular mechanical
yssynchrony with CRT-OFF compared with that of
Figure 3 Example of Hemodynamic Changes During CRT-ON an
(A) Left ventricular inflow using pulsed-wave Doppler at the mitral valve leaflet tips. Pr
and late (A-wave) filling shortens left ventricular diastolic filling time, deceleration time
valve velocity time integral: all indicative of worse diastolic function. (B) Left v
gramming CRT-OFF leads to increased left ventricular pre-ejection times (onset
tract velocity time integral, indicative of worse left ventricular contractile perfor
phy. Color tissue Doppler sample placed at basal part of the septum (yellow)
delay is measured as the maximal time difference between onset of QRS and
walls. Note the appearance of a septal-to-lateral wall motion delay as an indica
closing; AVO  aortic valve opening. Continued on next page.RT-ON. cmpact of biventricular pacing on hemodynamic variables.
RT-OFF was associated with acute worsening of LV
ontractile performance, indicated by a statistically signifi-
T-OFF
ing cardiac resynchronization therapy (CRT)–OFF leads to fusion of early (E-wave)
ime between onset of QRS and end of A-wave (QA-time), and reduces mitral
lar outflow using pulsed-wave Doppler at left ventricular outflow tract. Pro-
o start of left ventricular ejection) and reduces the left ventricular outflow
. (C) Intraventricular dyssynchrony using color tissue Doppler echocardiogra-
teral wall (green) in an apical 4-chamber view. Septal-to-lateral wall motion
f regional velocities of myocardial systolic shortening between different
intraventricular mechanical dyssynchrony when CRT-OFF. AVC  aortic valved CR
ogramm
, and t
entricu
QRS t
mance
and la
peak o
tor ofant drop in CO (13%) and systemic systolic blood
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February 17, 2009:600–7 Persistent Hemodynamic Benefits of CRTressure (7%), as well as a statistically significant increase
n CVP (22%), systolic (12%) and diastolic (14%)
ulmonary artery pressure, and PCWP (24%, all p 0.001)
Fig. 2, Table 3). Figure 3 shows a typical example of the
etrimental hemodynamic changes assessed by echocardi-
graphy and invasive hemodynamic measurement when
RT was programmed from ON to OFF.
Subanalysis of patients implanted with a CRT device
or more than 6 months (n  26) versus between 3 to 6
onths (n  14) revealed similar detrimental effects of
emodynamic measurements when CRT was pro-
rammed OFF, regardless of implant duration. Also, the
agnitude of deterioration of hemodynamic parameters
uring CRT-OFF was similar in patients with LV
nd-diastolic volumes above or below the mean (assessed
t moment of CRT implant or at study enrollment), and
etween patients with ischemic or nonischemic etiology
data not shown).
Three patients had a significant and sustained improvement
f their hemodynamic (systolic blood pressure [8%], CVP
17%], PCWP [17%], and CO [15%]) (Table 4) and
chocardiographic measurements in CRT-OFF, rather than in
RT-ON. In all 3 patients, the CRT was programmed in a
Figure 3 Continued
(D) Pulmonary artery catheter tracings in pulmonary artery and pulmonary capillary
lary wedge pressure when CRT is programmed OFF.
elected Hemodynamic Changes in Patients Who Improved With C
Table 4 Selected Hemodynamic Changes in Patients Who Impr
Systolic Blood Pressure
(mm Hg)
Central Venous Pr
(mm Hg)
CRT-ON CRT-OFF CRT-ON C
Patient #1 86 92 13
Patient #2 93 95 16
Patient #3 106 123 11RT  cardiac resynchronization therapy.ermanent VVI back-up mode. Two patients had an inade-
uate anterolateral LV lead position and were scheduled for
evision of their LV lead. The other patient had a QRS
omplex of 114 ms, and it was decided to keep the CRT device
n a back-up pacing mode.
iscussion
his mechanistic observational study provides detailed
chocardiographic and invasive hemodynamic measure-
ents to determine the relative contributions of biventricu-
ar pacing in patients with decompensation of their ad-
anced heart failure despite chronic CRT therapy. The key
nding is that long-term CRT continues to provide hemo-
ynamic augmentation in a patient population typically
ategorized as clinical and echocardiographic “nonre-
ponders” to CRT. These observations challenge the pre-
ailing belief that patients with symptomatic disease pro-
ression have not derived benefit from CRT and are
nonresponders.” In a subset of patients with serial mea-
urements of LV volumes, we observed that improvement of
emodynamic derangements through successful resynchro-
position. Note the increase in pulmonary artery pressure and pulmonary capil-
F
With CRT-OFF
Pulmonary Capillary
Wedge Pressure
(mm Hg)
Cardiac Output
(l/min)
F CRT-ON CRT-OFF CRT-ON CRT-OFF
13 11 4.5 5.0
16 13 3.6 4.8
11 9 3.9 4.0wedgeRT-OF
oved
essure
RT-OF
11
13
9
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Persistent Hemodynamic Benefits of CRT February 17, 2009:600–7ization therapy itself is not always sufficient to avert
rogressive LV remodeling.
The present study is the first to investigate the effects of
hronic CRT on invasive hemodynamics in patients who
id not exhibit beneficial reverse remodeling at a time
eriod long after implantation. Importantly, invasive hemo-
ynamic and echocardiographic assessments were per-
ormed with CRT-ON and CRT-OFF in close temporal
roximity, providing a more accurate measure of the extent
f acute hemodynamic deterioration in the absence of
iventricular pacing support, with a minimized likelihood
or time-dependent changes in factors such as pre-load or
eart rate to confound the analysis. The improvement in
iastolic filling is largely dependent on the restoration of a
ore physiologic AV interval. Additionally, improvement
n CO can be achieved through restoration of contractile
oordination, which subsequently leads to reduction in LV
lling pressures. These benefits were lost acutely when CRT
as programmed OFF. This relative “inotropic” effect can
e achieved at reduced oxygen demand (18), and the
emodynamic benefits appear to be consistent with
revious reports from patients shortly after their device
mplantation (4,5).
The focus on achieving reversal of LV remodeling with
RT stems from the wide acceptance that “resynchronized”
lectrical-mechanical coupling results in changes in cardiac
tructure and performance, which are primarily responsible
or changing the disease course in patients with heart
ailure. Indeed, prevention of cardiac remodeling improves
rognosis in heart failure, and numerous studies have shown
hronic CRT to be linked with reverse remodeling
2,3,10,19–21). Though the clinical and echocardiographic
esponses to CRT may vary significantly among individuals
nd heart failure etiology, this does not always appear to
ranslate into a greater effect on clinical outcomes. Also,
atients with nonischemic heart disease derive more im-
rovement in ventricular function and seem to exhibit a
reater improvement in survival after CRT (22–25). There-
ore, it is important to recognize that like any effective drug
r device therapy for patients with heart failure, response to
herapy can be heterogeneous. In the case of CRT, various
actors that may affect the efficiency of resynchronization
nclude (but are not limited to) extent and location of scar
issue and viable myocardium, the appropriateness of lead
ositioning, inadequate delivery of LV pacing, the presence
f concomitant rhythm abnormalities, suboptimal device
rogramming, or absence of myocardial contractile reserve
4,16,26,27). While many of these factors may directly
nfluence the ability of CRT to provide beneficial hemody-
amic effects, patients in our study population had fulfilled
tandard inclusion criteria including significant electrical
yssynchrony (QRS duration) for CRT at the time of
mplantation, and the aforementioned standard reasons for
ack of response could not account for the lack of reverse
emodeling. dIt is, therefore, likely that unrecognized contributors of
isease progression (e.g., progressive myocyte dysfunction,
poptosis, chamber size, and geometry) that may be inde-
endent of hemodynamic derangements may directly influ-
nce the clinical and echocardiographic responses to CRT.
uch contributors may also affect responses to any thera-
eutic intervention. Hence, lack of clinical or echocardio-
raphic responses despite successful resynchronization
hould not directly imply lack of acute or chronic hemody-
amic benefits from CRT. Instead, the appropriate inter-
retation for our “nonresponder” population should con-
ider the possibility that the hemodynamic augmentation
fter successful resynchronization by CRT may not be
ufficient to warrant a persistent meaningful change in the
atural history of heart failure disease progression but rather
ay slow down the disease progression. In fact, our group
nd others have suggested that the presence of alterations in
olecular expression of myocardial contractile genes after
RT is more predictive of clinical and echocardiographic
esponses than effective reduction in baseline dyssynchrony
r contractile reserve (20,28). In addition, lead position and
ts incumbent role in any evaluation for suboptimal re-
ponses to CRT remains an unknown until precise mecha-
isms of CRT are elucidated.
tudy limitations. It is important to recognize that this is
ot a randomized comparison, even though echocardio-
raphic analyses were made independent of any knowledge
f clinical or hemodynamic data. Our observations do not
xclude the possibility of improving response by lead repo-
itioning, although87% of LV leads were deemed to be in
n appropriate position and significant reduction in electri-
al and mechanical dyssynchrony were observed in our
opulation. We also cannot exclude the possibility that early
emodynamic changes during CRT-OFF might not reflect
ore long-term ones and that optimization of AV and
entriculo-ventricular timings at the time of implantation
ay have provided better clinical and echocardiographic
esponses leading to fewer patients with disease progression,
lthough that strategy has yet to be proven. No acute
ost-implant hemodynamic data were gathered though
arly clinical improvement in NYHA functional class, and
tabilization of LV volumes suggests at least some early
enefits of CRT. However, despite continuous hemody-
amic support, patients had experienced progressive LV
emodeling at the time of study enrollment. Despite the
oal to reach maximally tolerated, guideline-recommended
edical therapy as specified in the Methods section, the
hallenge of up-titration in this patient population with
dvanced heart failure (32% inotropic agents during hospi-
alization) is apparent to most practicing physicians. How-
ver, at the time of CRT implant, all patients were on
ptimal, stable medical therapies. Although the echocardio-
raphic techniques used in this study have been widely
onsidered as relatively robust measures, the gold standard
or defining and quantifying dyssynchrony is still being
ebated and is currently undergoing prospective validation.
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espite adverse cardiac remodeling and heart failure de-
ompensation, CRT continues to provide persistent hemo-
ynamic augmentation in the failing heart. Our data show
hat detrimental disease progression may not be explained
olely by diminishing beneficial hemodynamic contributions
f successful resynchronization. Our data also illustrate that
lack of clinical and/or echocardiographic response should
ot be interpreted as a failure to deliver hemodynamic
enefits from successful CRT.
eprint requests and correspondence: Dr. W. H. Wilson Tang,
ection of Heart Failure and Cardiac Transplantation Medicine,
epartment of Cardiovascular Medicine, Cleveland Clinic, 9500
uclid Avenue, Desk J3-4, Cleveland, Ohio 44195. E-mail:
angw@ccf.org.
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